Trials / Terminated
TerminatedNCT00127595
Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract
A Phase II Monocentric Study of Oxaliplatin in Combination With Gemcitabine in Patients With Advanced/Metastatic Transitional Cell Carcinoma of the Urothelial Tract
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 28 (planned)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase II monocentric study of oxaliplatin (Ox) in combination with gemcitabine (Gem; GEMOX) in patients (pts) with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gemcitabine, oxaliplatin |
Timeline
- Start date
- 2002-01-01
- Completion
- 2005-04-01
- First posted
- 2005-08-08
- Last updated
- 2005-08-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00127595. Inclusion in this directory is not an endorsement.